Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
16 Results Found
AHA Amicus Brief in Supreme Court Challenges 5th Circuit Ruling on Preventive Care Service Coverage
Amici and their member-hospitals know better than anyone that preventive healthcare services are essential for the early diagnosis and treatment of life-threatening illnesses for millions of Americans. Amici write to offer guidance, from hospitals’ perspectives, on the harmful impact that upholding the Fifth Circuit’s decision would have on the American healthcare system and all who depend on it.
AHA, Others File Amicus Brief in Fourth Circuit in Support of Maryland 340B Contract Pharmacy Law
AHA, others file amicus brief in Fourth Circuit in support of Maryland 340B contract pharmacy law.
AHA Amicus Brief Challenges MultiPlan, Inc. Motion to Dismiss Antitrust Litigation
Commercial insurance reimbursements comprise the majority of many hospitals’ revenue. Moreover, because government programs like Medicare do not cover the costs of providing care, commercial reimbursements can be the difference between losing money, breaking even, or earning a sustainable margin.
Lawsuit Challenges Federal Rule That Ties Providers Hands in Efforts to Reach Their Communities
The American Hospital Association (AHA), joined by the Texas Hospital Association, Texas Health Resources, and United Regional Health Care System, today sued the federal government to bar enforcement of an unlawful, harmful, and counterproductive rule that has upended hospitals’ and health systems’ ability to share health care information with the communities they serve, analyze their own websites to enhance accessibility, and improve public health.
Case Complaint: AHA, THA, THR, United Health Care System v. Rainer
The American Hospital Association and the Texas Hospital Association (Associations), along with Texas Health Resources and United Regional Health Care System (Hospitals), bring this action because the federal government is threatening to enforce against hospitals and health systems a new rule that is flawed as a matter of law, deficient as a matter of administrative process, and harmful as a matter of policy.
AHA et al Amicus Brief Re: 340B in Novartis v. Morrissey Litigation
AHA et al Amicus Brief to Prevent Injunction Against 340B Pricing for Contract Pharmacy Arrangements in Novartis v. Morrissey Litigation
AHA, FAH Amicus Brief in FTC Non-Compete Case
While the AHA respects the FTC’s efforts to address issues of genuine unequal bargaining power between certain employers and certain types of workers, the FTC proposed non-compete rule would profoundly transform the health care labor market – particularly for physicians and senior hospital executives.
AHA, Others File Amicus Brief in Maryland to Prevent Injunction Against 340B Pricing for Contract Pharmacy Arrangements
UNITED STATES DISTRICT COURTFOR THE DISTRICT OF MARYLAND
AHA, Others File Brief in Missouri to Prevent Injunction Against 340B Pricing for Contract Pharmacy Arrangements
The American Hospital Association, 340B Health, and the American Society of Health-System Pharmacists (collectively, the “Proposed Amici”) respectfully move this Court for leave to file the attached amicus curiae brief in support of Defendants Attorney General Andrew Bailey, President of the Missouri Board of Pharmacy James L. Gray, Vice President of the Missouri Board of Pharmacy Christian S. Tadrus, and Members of the Missouri Board of Pharmacy Douglas R. Lang, Colby Grove, Anita K. Parran, Tammy Thompson, and Darren Harris’s Motion to Dismiss and Opposition to Plaintiff Novartis Pharmaceuticals Corporation’s Motion for Preliminary Injunction (Exhibit A).
Amicus Brief: AHA 340B Health Arkansas Hospital Association in support of Arkansas’ 340B Drug Pricing Nondiscrimination Act
Amicus Brief: AHA 340B Health Arkansas Hospital Association in support of Arkansas’ 340B Drug Pricing Nondiscrimination Act against a challenge brought by PhRMA.